BMS establishes cancer vaccine network
June 1, 2012Research and Development, Sales and Marketing
Bristol-Myers Squibb has formed a network of ten institutions to advance work on using the body’s own immune system to …
ROCK medical communications appoints two new account managers
June 1, 2012Medical Communications, Research and Development, Sales and Marketing ROCK, medical communications, pharma appointment
ROCK medical communications has appointed two new team members: Suzanne Smith and Nicola Wood. Suzanne joins from Chameleon Communications, where …
Boehringer appoints new executive director of Consumer Healthcare Marketing
May 31, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim
Boehringer Ingelheim has announced the appointment of Ross Ullman as the executive director marketing of the Consumer Healthcare division. In …
Vertex admits blunder over drug data
May 31, 2012Sales and Marketing Kalydeco, Kalydeco., Vertex, cystic fibrosis
Vertex has been embarrassed after it released claims for its pipeline drug VX-809 which turned out to be incorrect. The …
HGS shareholder challenges ‘poison pill’
May 31, 2012Sales and Marketing Benlysta, GSK, HGS, hostile bid
The saga of GlaxoSmithKline’s attempt to take over Human Genome Sciences (HGS) has taken another turn with legal action by …
UK doctors vote to strike
May 30, 2012Medical Communications BMA, GPs, NHS, UK government, doctors, strike
Doctors will take industrial action for the first time in almost 40 years, the British Medical Association has confirmed. The …
Europe’s CMO market set to double by 2018, says F&S
May 30, 2012Manufacturing and Production CMO, Europe, F&S, R&D, Taylor, manufacturing
The European market for pharmaceutical contract manufacturing will double from a value of around $10 billion last year to almost …
Pharma relieved as Senate backs FDA fees
May 30, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing FDA, PDUFA, PhRMA, US
The US Senate has approved a law that will continue to allow pharma firms to help fund the FDA. The …
Photo story: GSK’s 2012 legacy
May 30, 2012Research and Development Andrew Witty, GSK, Olympics 2012
Tuesday May 29, 2012: GlaxoSmithKline chief executive, Sir Andrew Witty makes a speech at a conference at the company’s headquarters …
GSK starts combination trial for melanoma
May 30, 2012Research and Development, Sales and Marketing GSK, R&D, Roche, Zelboraf, melanoma
GlaxoSmithKline has begun a combination trial for two of its investigational skin cancer drugs. The firm will combine dabrafenib, its …
UK Prix Galien shortlist announced
May 30, 2012Business Services, Medical Communications, Research and Development, Sales and Marketing Bayer, Janssen, Xarelto, awards, prix galien
The UK award for the most innovative new drug has been moved a step closer with the release of a …
Onyx appoints Brian Jolly to commercial team
May 30, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing CMO, Onyx, manufacturing
Onyx Scientific the chemistry and manufacturing specialist has bolstered its business development team with the appointment of a new director. …
Landmark CF treatment set for European approval
May 30, 2012Sales and Marketing CHMP, Europe, Kalydeco, Vertex, cystic fibrosis
A European committee is recommending the approval of Vertex’s first-in-class treatment for cystic fibrosis. Kalydeco (ivacaftor) is a landmark in …
Government outlines new commissioning landscape
May 29, 2012CCG, NHS, PCTs, commissioning, health reforms
The government has outlined the new commissioning landscape in England as GPs look to take over commissioning responsibility. The NHS …
Sanofi/Regeneron cholesterol drug reaches Phase III
May 29, 2012Research and Development, Sales and Marketing Amgen, PCKS9, Regeneron, SAR236553, Sanofi
Sanofi and Regeneron’s anti-cholesterol drug has impressed in a mid-stage trial, and will now progress into Phase III. The firms’ …
Lundbeck’s Alzheimer’s drug shows promise
May 29, 2012Research and Development, Sales and Marketing Alzheimer's, Lundbeck
Lundbeck’s Alzheimer’s candidate Lu AE58054 has shown signs in a phase II study of helping patients’ mental activity. Sufferers receiving …
Pharma manufacturing news in brief
May 29, 2012Manufacturing and Production Adienne Pharma & Biotech, Hospira, Neuroptis Biotech, Provence Technologies, Selexis and Florida Biologix, baxter
Hospira overfilled Carpuject cartridges, high-potency certification at Baxter, plus updates from Provence Technologies, Selexis and Florida Biologix.
EMA backs MabThera despite contamination issue
May 29, 2012Manufacturing and Production EMA, MabThera, Phil Taylor, Roche, manufacturing
The European Medicines Agency has completed a safety review of Roche’s MabThera convened after bacterial contamination was discovered in bioreactors …
Merck extends biocatalysis collaboration with Codexis
May 29, 2012Manufacturing and Production Codexis, Merck, Phil Taylor, Victrelis, manufacturing
Biocatalyst specialist Codexis has signed a three-year extension of its catalyst and process development collaboration with Merck to develop enzymes …
European OK for Pradaxa, but more details required
May 29, 2012Research and Development, Sales and Marketing Boehringer, CHMP, EMA, Europe, Pradaxa
The European Medicines Agency says that Boehringher’s Pradaxa can stay on the market, but will need more safety information. The …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
